Case: 1.SEBI, 2.In Re: Ranbaxy Laboratories Ltd. Vs 1.Mukesh Babu Securities Ltd.. Securities and Exchange Board of India

Party Name1.SEBI, 2.In Re: Ranbaxy Laboratories Ltd. Vs 1.Mukesh Babu Securities Ltd.
JudgesV.K. Chopra, Member
IssueCompany Law
Judgement DateMarch 16, 2007
CourtSecurities and Exchange Board of India

Order:

V.K. Chopra, Member

  1. Securities and Exchange Board of India (hereinafter referred to in short as "SEBI") conducted investigation into the affairs relating to buying, selling and dealing in the shares of Ranbaxy Laboratories Ltd.

  2. SEBI, after considering the investigation report, appointed an Enquiry Officer vide Order dated November 29, 2002 to enquire into the violations allegedly committed by the broker M/s. Mukesh Babu Securities Ltd (hereinafter referred to in short as "the Broker") under the provisions of Regulation 4(a), (b) (c) & (d) of the SEBI (Prohibition of Fraudulent and Unfair Trade Practices relating to Securities Market) Regulations, 1995, Regulation 7 read with schedule II, Clause A(3) and (4) of SEBI (Stock Brokers and Sub-Brokers) Regulations, 1992 and Rules, Regulations and Bye-laws of Stock Exchange.

  3. The Enquiry Officer submitted a report dated February 18, 2005. I have perused the said report and the other material documents relied upon by him to arrive at a conclusion in the proceedings against the Broker in the matter of Ranbaxy Laboratories Ltd. It is observed from the said report that the Enquiry Officer has observed/recommended as under:

    From the details provided by the member broker, it is observed that the alleged purchase order got matched against a large number of sale transactions at different prices in the price range of Rs 538.25 to Rs 542.00. Only some of the transactions got matched at the highest price within the range i.e. at Rs 542.00. On the same day, a total of...

To continue reading

Request your trial